AUS
NZ
UK
CA
USA
IND
Health
Why Scholar Rock’s Workforce Expansion Is Drawing Attention Across Biotechnology
June 14, 2026 10:10 PM PDT| By Anmol KhazanchiScholar Rock expands organizational capabilities through new employee equity awards as the company continues advancing therapies for neuromuscular diseases.
Can S&P 500 Healthcare Giant Abbott Boost Growth With Libre Duo?
June 14, 2026 01:01 PM PDT| By Anmol KhazanchiAbbott Laboratories (NYSE:ABT) advances healthcare innovation through devices, diagnostics, and nutrition products, reinforcing its global presence and role in the S&P 500 Index .
Is NYSE Composite Pressure Mounting as UHS Faces Regulatory Scrutiny?
June 14, 2026 11:28 AM PDT| By Anmol KhazanchiUniversal Health Services (NYSE:UHS) operates across acute and behavioral care, with regulatory developments shaping operations within the NYSE Composite Index healthcare landscape.
Why Is Veeva Systems Stock Trending Right Now
June 13, 2026 09:59 PM PDT| By Anmol KhazanchiVeeva Systems remains closely watched as healthcare technology developments, software platform discussions, and digital transformation themes drive visibility.
Why Is CVS Health Stock Trending Right Now
June 13, 2026 04:52 AM PDT| By Anmol KhazanchiCVS Health remains widely followed as healthcare service expansion, technology initiatives, and institutional ownership developments support continued visibility.
Is Amgen Still Reasonable After Its Strong Run?
June 13, 2026 04:02 AM PDT| By Anmol KhazanchiAmgen's valuation debate centres on Horizon integration, cash flow strength, biotech risks, and whether strong gains already reflect future business expectations.
Pfizer Draws Fresh Focus As Growth Strategy Evolves
June 13, 2026 02:09 AM PDT| By Anmol KhazanchiPfizer continues navigating industry change through innovation, pipeline expansion, strategic integration, and portfolio diversification, while market participants assess how these initiatives may influence long-term business direction.
Harmony’s Next Growth Phase Faces A Bigger Test
June 13, 2026 01:20 AM PDT| By Anmol KhazanchiNew clinical findings and ongoing regulatory initiatives are helping shape Harmony Biosciences' efforts to expand beyond its core franchise and strengthen its broader neurology strategy.
GE HealthCare Stock Draws Attention After A Sharp Pullback
June 13, 2026 12:47 AM PDT| By Anmol KhazanchiMedical equipment demand, valuation signals, imaging needs, and hospital technology spending keep this healthcare name in focus as markets reassess its longer-term business outlook.
Evolent Health Leads Healthcare Technology Sector Focus
June 12, 2026 02:22 PM PDT| By Anmol KhazanchiEvolent Health continues attracting attention as healthcare providers embrace digital transformation, value-based care initiatives, analytics platforms, and technology-driven solutions designed to improve operational efficiency and patient outcomes.
Danaher Masimo Deal Strengthens S&P 500 Healthcare Growth Story
June 12, 2026 02:18 PM PDT| By Anmol KhazanchiDanaher’s Masimo acquisition expands its healthcare technology portfolio, adding patient monitoring and sensor capabilities while strengthening its diagnostics platform and connected care growth story.
Johnson & Johnson Lens Rollout Lifts Dow Healthcare Focus
June 12, 2026 01:25 PM PDT| By Anmol KhazanchiJohnson & Johnson’s TECNIS PureSee rollout strengthens its eye care portfolio, adding focus to cataract surgery innovation, surgeon adoption, medical technology growth, and broader healthcare market relevance.
Pfizer Draws Fresh Attention As Pipeline Activity Accelerates
June 12, 2026 12:33 PM PDT| By Anmol KhazanchiPfizer’s latest share move reflects renewed focus on rare-disease progress, research activity, dividend appeal, and the broader challenge of sustaining growth amid patent pressure.
Is Eli Lilly's Growth Story Still Gaining Strength?
June 12, 2026 12:28 PM PDT| By Anmol KhazanchiRecent drug milestones have strengthened focus on Eli Lilly's pipeline, valuation outlook, and future growth opportunities across obesity, diabetes, and dermatology treatments.
Adaptive Biotechnologies Momentum Lifts Nasdaq Healthcare Focus
June 12, 2026 12:25 PM PDT| By Anmol KhazanchiAdaptive Biotechnologies continues advancing immune system research through innovative sequencing technologies, supporting precision medicine, disease monitoring, and diagnostic development within the evolving biotechnology and healthcare landscape.
Is Doximity Struggling After Revenue Miss?
June 12, 2026 09:53 AM PDT| By Anmol KhazanchiDoximity reported softer quarterly results, expanded AI initiatives, and attracted legal attention while maintaining a significant healthcare technology presence within the Russell 1000 Index .
Why Is Novo Nordisk Stock Trending Right Now
June 12, 2026 12:25 AM PDT| By Vivek SinghNovo Nordisk remains a widely followed healthcare company as valuation discussions, treatment development themes, and pharmaceutical activity shape ongoing attention.
Regeneron Keeps Biotech Execution In Focus Amid Market Volatility
June 11, 2026 11:37 AM PDT| By Anmol KhazanchiBiotechnology remains under scrutiny as market volatility increases focus on pipeline quality, product demand, margin discipline, cash flow, and company-specific execution across regulated healthcare markets.
Edwards Lifesciences Stock Watched As Procedure Recovery Matters
June 11, 2026 11:31 AM PDT| By Anmol KhazanchiProcedure recovery, hospital utilization, product adoption, and operating discipline remain central as healthcare names face a more selective market backdrop.
Cencora Drug Distribution Story Gains Healthcare Market Attention
June 11, 2026 11:28 AM PDT| By Anmol KhazanchiSpecialty drug demand, healthcare distribution, working capital discipline, margin control, customer retention, and financial flexibility continue shaping Cencora’s role in the U.S. healthcare market.
